Skip Navigation

Adalvo Nominated for Six Global Generics & Biosimilars and CPHI 2024 Awards

Achievements
13 September 2024

At Adalvo we are driven by our commitment to our partner network, dedicated to making a meaningful impact and improving patient lives globally.

We are proud to share that Adalvo has been nominated for six prestigious awards at two major industry events: the CPhI 2024 Awards and the Global Generics & Biosimilars Awards 2024.

CPhI 2024 Awards Nominations:

  • Future Leader of the Year – Paulo Rodriguez, VP Business Development, Europe
  • At the Heart of Pharma – Recognising our CSR and ESG initiatives

Global Generics & Biosimilars Awards 2024 Nominations:

  • Leader of the Year – Anil Okay, CEO
  • Business Development of the Year
  • Value-Added Initiative of the Year
  • Industry Partner of the Year

Winners will be announced at the CPhI Awards Ceremony in Milan on October 8th, 2024, and at the Global Generics & Biosimilars Awards on October 9th, 2024.

We are grateful for these nominations, which reflect our team's hard work and dedication. We look forward to seeing you in Milan!

At Adalvo, there are no half-measures – we are always on target. When your mission is to be faster and stronger than your competitors, you need a winning team driving your vision forward. 

Partner up now!